Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

A -- SN07-37 BLOOD PHARMING

Active
SN07-37Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Sciences Office (DSO) of DARPA is conducting a Blood Pharming Workshop on June 29, 2007, aimed at advancing research into automated progenitor cell-based systems for producing universal donor red blood cells (Type O negative) without relying on donors. This initiative focuses on developing an efficient, large-scale culture system that supports the entire process from progenitor cell expansion through RBC differentiation to a packaged, transfusion-ready product. The workshop will be held in Arlington, VA, and is designed to catalyze collaboration among experts in progenitor cell biology, erythroid differentiation, RBC physiology, automated cell culture technologies, and related fields, with an emphasis on creating integrated teams experienced in FDA approval processes for transfusable products. Participation is limited to 50 attendees, with a maximum of two representatives per institution. Registration and poster submission deadlines are June 20, 2007, with no attendance fee. Participants are encouraged to submit detailed posters showcasing relevant research to stimulate discussion and team formation. The workshop seeks to foster partnerships among specialists capable of addressing the technical challenges of producing donor-less red blood cells for combat casualty care. Additional information and registration details are available through designated contacts at DARPA, and materials from the event can be requested by those unable to attend.

General Info

DARPA hosts Blood Pharming Workshop June 29, 2007, advancing universal donor red blood cell production.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts2 people available
OfficeARLINGTON, VA, 222032114, USA
Office AddressARLINGTON, VA, 222032114, USA
Contacts

Full Description

Show more
Special Notice SN07-37: BLOOD PHARMING Workshop;WORKSHOP DATE: June 29, 2007; REGISTRATION DEADLINE: June 20, 2007; TECHNICAL POC: Dr. Jon Mogford, DARPA/DSO, Ph: (571) 218-4928, Fax: (703) 741-7845; Email: BAA07-21@darpa.mil; URL: http://www.eventmakeronline.com/dso/View/index.asp?MeetingID=524 The Defense Sciences Office (DSO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Workshop to discuss innovative research that will enable development of an automated progenitor cell-based culture system to produce a donor-less supply of universal donor (Type ?O? negative) red blood cells (RBCs) for combat casualty care. It is envisioned that RBCs of normal structure and function will be produced and that the automated culture system would process cells from starter population to packaged RBC unit ready for transfusion. Complete program metrics will be specified in a forthcoming Broad Agency Announcement (BAA). The Blood Pharming Workshop will be held at 3601 Wilson Blvd, Suite 600, Arlington, VA, 22201. The goal of the workshop is to explore: 1) culture techniques that stimulate and support the efficient and large-scale production of mature red blood cells from human progenitor cells and 2) automated cell culture systems capable of large-scale implementation of progenitor cell expansion and RBC differentiation protocols. Workshop participants are strongly encouraged to prepare posters describing previous or potential research in the area in order to facilitate discussions and formation of well-rounded teams. It is expected that the successful team will possess expertise in human progenitor cell biology and erythroid differentiation; RBC physiology, cellular support matrices/scaffolds; automated cell culture systems, and cell sorting, purification and packaging. In addition, teams should be led by a strong System?s Integrator and have experience with the FDA approval process for transfusable products. For poster submissions, a detailed description of the poster must be submitted by June 20, 2007, 4:00PM ET. A maximum of 20 4ft x 4ft posters can be accommodated. There is no fee for the Blood Pharming Workshop. Details on the workshop, including registration and poster information, can be found at the following URL: http://www.eventmakeronline.com/dso/View/index.asp?MeetingID=524. The password for login is: arlington Registration is limited by the venue capacity (maximum of 50 people, maximum 2 from each institution). The registration cutoff date is June 20, 2007, or at attendance capacity, whichever comes first. If there is additional space available after the registration deadline, institutions will be permitted additional participants on a first-come, first-serve basis. Further administrative information is available from Ms. Carol Higgins (Carol.Higgins.ctr@darpa.mil). Additional technical information can be obtained from Dr. Jon Mogford (Jon.Mogford@darpa.mil). Please refer to the Blood Pharming Workshop in any correspondence. This special announcement is not a request for proposals. For those interested but unable to attend, requests for DARPA materials presented at the workshop should be directed to Ms. Carol Higgins.

Similar Contracts

Same NAICS industry code

NAICS: 561920
New
SLED
RFP: Project Manager and Event Consultant for Martinsville Speedway 80th Anniversary Race Season
Solicitation # RFP-130413
The West Piedmont Planning District Commission is seeking qualified individuals or firms to provide professional assistance for the 2027 season celebrations marking the 80th anniversary of Martinsville Speedway and the 250th anniversary of Henry County. The solicitation, identified as RFP-130413, offers two distinct roles: a Crew Chief to serve as Project Manager and a Track Manager to act as an Event Consultant. The Crew Chief will focus on overall project management, partner engagement, and sponsorship support, while the Track Manager will handle technical event planning, site logistics, and operational safety. Proposers may apply for one or both roles, provided they submit separate scope narratives and pricing for each. The engagement is expected to last 18 months, beginning in late 2026 and continuing through the post-event closeout of the 2027 initiative. While some work can be performed remotely, a regular on-site presence in the Martinsville-Henry County area is required for key meetings and events. The anticipated budget for the initiative is 345,000 dollars, and proposers must specify whether their pricing is fixed fee, hourly, or a hybrid model. Proposals must be submitted in PDF format to info@mhcchamber.com, with the review process scheduled to begin on November 12, 2026. Evaluation will be based on a weighted matrix scoring personnel qualifications and experience from 1 to 5, and short-listed candidates may be invited for interviews.
West Piedmont Planning District Commission

POSTED

1 day ago

DEADLINE

in 23 days
View Details
NAICS: 561920
New
SLED
2027 TEXAS WOMEN'S LEADERSHIP CONFERENCE AUDIO VISUAL SERVICES AND SUPPORT
Solicitation # 301-27-08828
The Office of the Governor of Texas, through the Governor’s Commission for Women, is soliciting proposals for comprehensive audio-visual equipment, technical services, and onsite personnel for the 2027 Texas Women’s Leadership Conference and Legislative Luncheon. The event is scheduled for February 2-3, 2027, at the JW Marriott Austin. The contract term for monthly service fees extends from the execution date through August 31, 2027. Proposals are due by November 16, 2026, and must be submitted as a printed response with a searchable PDF copy on a USB drive; email submissions are not accepted. The contract will be awarded based on best value, with past performance evaluated on a pass/fail basis. Selected vendors must provide an account manager and qualified staff, maintain an accounting system compliant with GAAP or IAS, and adhere to various state and federal regulations, including the Foreign Corrupt Practices Act, the Americans with Disabilities Act, and Texas cybersecurity training requirements. Payment is processed monthly in accordance with the Texas Prompt Payment Act, provided that deliverables meet the quality standards determined by the Office of the Governor. Required submission documents include a cost proposal, a HUB subcontracting plan, conflict of interest disclosures, and certifications regarding bidder status and anti-corruption compliance.
Governor – Executive

POSTED

4 days ago

DEADLINE

in 27 days
View Details
NAICS: 561920
New
Federal
IDIQ - Reverse Trade Missions, Conferences, Workshops, Trainings, and Other Events
Solicitation # 1131PL27R0001
The U.S. Trade and Development Agency (USTDA) is establishing a multiple-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract to secure a pool of qualified contractors for the planning and implementation of partnership-building activities. These activities include reverse trade missions, conferences, forums, workshops, and trainings, which may be conducted in person, virtually, or in a hybrid format both within the United States and overseas. The scope of work encompasses a full range of event management services, including project management, venue and vendor coordination, international travel logistics, participant recruitment, and post-event evaluation. The contract has a total ceiling of 100 million dollars, with a twelve-month base ordering period and four twelve-month option periods. This procurement is a partial small business set-aside under NAICS 561920, with the government intending to award up to 15 contracts, at least five of which are reserved for small businesses. Task orders are capped at 3 million dollars each, and individual contractors are limited to 5 million dollars in services per year. Pricing follows a firm-fixed-price model for nine core labor categories and a cost-reimbursable model for other direct costs. Awards are based on a best-value tradeoff, where technical expertise and relevant past performance are considered significantly more important than price. Contractors must adhere to strict quality control standards, including the mandatory human review and disclosure of any AI-generated content used in deliverables.
US Trade And Development Agency

POSTED

4 days ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

4 days ago

DEADLINE

in 26 days
View Details
NAICS: 541715
New
Federal
Intrinsic Market Resilience (IMR)
Solicitation # DARPA-PS-26-138
The Intrinsic Market Resilience (IMR) program, solicited by the DARPA Information Processing Techniques Office under DARPA-PS-26-138, is a 32-month initiative spanning Fiscal Years 2027 through 2029. The program aims to protect essential U.S. economic sectors from systemic risks and adversarial attacks targeting the public interfaces of modern electronic markets. By combining Large Language Model (LLM) automation with rigorous mathematical modeling, IMR seeks to develop tools that automatically translate informal regulatory and technical specifications into formal models to identify hidden weaknesses and recommend structural repairs. The work is divided into three technical areas: TA1 focuses on modeling and analysis, TA2 on resiliency and repair, and TA3 on establishing test and evaluation frameworks to validate the outputs of the first two areas. This procurement is conducted as an Other Transaction (OT) for Prototype Agreement under 10 U.S.C. 4022, with anticipated award ranges of 4.5 to 5 million dollars for TA1, 2.5 to 3 million dollars for TA2, and 5 to 6.5 million dollars for TA3. Eligible participants include small businesses, nonprofit research institutions, and nontraditional defense contractors. Proposers must adhere to strict security requirements, including CMMC Level 1 compliance at award and CMMC Level 2 status or a detailed compliance plan. All information must be handled according to NIST 800-171 and DFARS 252.204-7012 standards. Evaluation is based on technical approach, qualifications, technology transition viability, price, and security, with a particular emphasis on innovation and the feasibility of the proposed technical solution.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in about 2 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS